Top Markets
#1 Tornado Cash Tornado Cash +5.42%
#2 MVL MVL +3.98%
#3 Nockchain Nockchain +3.41%
#4 Story Story +3.25%
#5 Dual Dual +2.86%
#6 TENDIES TENDIES +2.76%
#7 UnifAI Network UnifAI Network +2.62%
#8 Figure Heloc Figure Heloc +2.55%
#9 WAX WAX +2.47%
#10 Seeker Seeker +2.13%
Coin of the day
Tornado Cash Tornado Cash
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
AP Biosciences Inc AP Biosciences Inc

AP Biosciences Inc

6945
Classifica tra le azioni #16392
AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company... AP Biosciences Inc. is a pioneering clinical-stage biopharmaceutical company dedicated to the research and development of bispecific antibody drugs, aiming to fulfill critical unmet medical needs. Its robust pipeline features several promising candidates: Leading the pack, IBI302 is in Phase III clinical trials for the treatment of neovascular age-related macular degeneration (nAMD). Further along, AP505 is undergoing Phase I clinical trials for various solid tumors. AP203, also in Phase I, is being investigated for non-small cell lung cancer, head and neck squamous cell carcinoma, and esophageal squamous cell carcinomas. In earlier development, AP402 is currently in the pre-clinical research phase, focusing on breast cancer patients. Additionally, AP601 is also in pre-clinical research, targeting a broader spectrum of malignancies including lung cancer, pancreatic cancer, bladder cancer, ovarian cancer, and other solid tumors. Founded in 2013, the company maintains its headquarters in Taipei City, Taiwan.
Prezzo delle azioni
$3.06
Capitalizzazione di mercato
$296.40M
Variazione (1 giorno)
-2.24%
Variazione (1 anno)
-22.64%
Paese
TW
Scambia AP Biosciences Inc (6945)

Categoria

Healthcare
Storico del prezzo dell'azione per AP Biosciences Inc (6945)
Prezzo di chiusura più alto: $3.06 il 2026-09-01

Prezzo di chiusura più basso: $2.10 il 2023-07-01
Storico del prezzo dell'azione di AP Biosciences Inc dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -13.12%
2025 237.19%
2024 4.26%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -10.53%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 6.90%
CH